Tumour antigens and optimism.
出版信息
Br Med J. 1979 Jan 20;1(6157):149-50.
Abstract
摘要
相似文献
1
Tumour antigens and optimism.肿瘤抗原与乐观主义。
Br Med J. 1979 Jan 20;1(6157):149-50.
2
An introduction to tumour immunology.肿瘤免疫学导论
Arch Immunol Ther Exp (Warsz). 1983;31(6):795-808.
3
Novel antigenic markers of human tumor regression.
J Biol Response Mod. 1988 Feb;7(1):11-23.
4
Cellular and humoral immune responses of cancer patients to defined tumor antigens.癌症患者对特定肿瘤抗原的细胞免疫和体液免疫反应。
Cancer Chemother Biol Response Modif. 2001;19:385-93.
5
Human tumour-associated antigens: targets for monoclonal antibody-mediated cancer therapy.人类肿瘤相关抗原：单克隆抗体介导的癌症治疗靶点
Cancer Surv. 1985;4(1):271-90.
6
Tumour immunology: the end of the beginning.肿瘤免疫学：开端的结束。
Practitioner. 1982 Dec;226(1374):2010-20.
7
Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.使用针对肿瘤相关抗原的抗体或其基因进行癌症的免疫疗法和基因疗法。
Anticancer Res. 2003 Nov-Dec;23(6a):4377-81.
8
Tumour immunotherapy: the adjuvant treatment of the 21st century?肿瘤免疫疗法：21世纪的辅助治疗手段？
Eur J Surg Oncol. 2000 Jun;26(4):418-24. doi: 10.1053/ejso.1999.0908.
9
Tumour immunity.肿瘤免疫
Indian J Pathol Bacteriol. 1974 Apr;17(2):69-74.
10
Monoclonal antibodies in cancer immunotherapy.癌症免疫疗法中的单克隆抗体。
Clin Lab Med. 1992 Jun;12(2):201-16.
本文引用的文献
1
Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.恶性黑色素瘤中经照射的肿瘤细胞免疫接种及特异性淋巴细胞细胞毒性
Br Med J. 1971 May 8;2(5757):305-10. doi: 10.1136/bmj.2.5757.305.
2
Effect of active immunization with irradiated tumour cells on specific serum inhibitors of cell-mediated immunity in patients with disseminated cancer.用经辐射的肿瘤细胞进行主动免疫对播散性癌症患者细胞介导免疫的特异性血清抑制剂的影响。
Br J Cancer. 1973 Jul;28(1):25-35. doi: 10.1038/bjc.1973.67.
3
Neuraminidase immunotherapy of tumors in man.人肿瘤的神经氨酸酶免疫疗法。
Surg Gynecol Obstet. 1974 Nov;139(5):675-82.
4
Active immunotherapy as an adjunct to chemotherapy in the treatment of disseminated malignant melanoma: a pilot study.主动免疫疗法作为化疗辅助手段治疗播散性恶性黑色素瘤的一项初步研究。
Br J Cancer. 1975 Feb;31(2):143-56. doi: 10.1038/bjc.1975.19.
5
Immunotherapy of osteosarcoma patients with virus-modified tumor cells.用病毒修饰的肿瘤细胞对骨肉瘤患者进行免疫治疗。
Ann N Y Acad Sci. 1976;277(00):396-411. doi: 10.1111/j.1749-6632.1976.tb41717.x.
6
Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers.神经氨酸酶处理的自体肿瘤疫苗与卡介苗联合用于头颈癌的辅助免疫治疗和/或化疗。
Ann N Y Acad Sci. 1976;277(00):339-44. doi: 10.1111/j.1749-6632.1976.tb41712.x.
7
Active specific immunotherapy of human solid tumors.
Ann N Y Acad Sci. 1976;277(00):332-8. doi: 10.1111/j.1749-6632.1976.tb41711.x.
8
Immunology and immunotherapy of human-malignant melanoma: historic review and perspectives for the future.人类恶性黑色素瘤的免疫学与免疫治疗：历史回顾与未来展望
Semin Oncol. 1975 Jun;2(2):155-74.
9
Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.特异性主动免疫疗法并不能延长IIB期恶性黑色素瘤手术治疗患者的生存期，且可能会促进早期复发。
Br J Cancer. 1978 Apr;37(4):491-6. doi: 10.1038/bjc.1978.76.
10
Active specific immunotherapy of human solid tumors.
Va Med. 1978 Mar;105(3):221-3.
Zotero 插件